Features | DORIS-remission | LLDAS |
Main purpose | Defines a state of remission in SLE | Represents a state of low disease activity in SLE |
Disease Activity Score | Clinical SLEDAI=0 | SLEDAI-2K ≤4 with no activity in major organ systems (renal, CNS, cardiopulmonary, vasculitis, fever), and no haemolytic anaemia or gastrointestinal activity |
No new lupus disease activity compared with the previous assessment | ||
Physician Global Assessment | <0.5 (0–3) | ≤1 (0–3) |
Glucocorticoids | Prednisolone ≤5 mg/day or equivalent | Prednisolone ≤7.5 mg/day or equivalent |
Other treatments | Stable antimalarials, immunosuppressives and biologics | Well-tolerated standard maintenance doses of immunosuppressive drugs and approved biological agents |
CNS, central nervous system; DORIS, Definitions Of Remission In SLE; LLDAS, Lupus Low Disease Activity State; SLEDAI-2K, SLE Disease Activity Index 2000.